| Cardiovascular effects of cocaine: enhancement by yohimbine and atropine. | |
| | |
MedLine Citation:
|
PMID: 2913288 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The cardiovascular effects of cocaine, alone and in combination with yohimbine and/or atropine, were studied in dogs anesthetized with pentobarbital sodium. All dogs were instrumented for the measurement of arterial blood pressure, left ventricular contractile force, left circumflex coronary artery blood flow, lead II ECG and heart rate. Dogs were divided into two groups; one group received no pretreatment, the other group was pretreated with atropine sulfate, 2 mg/kg. Both groups received two i.v. doses of cocaine, 1 mg/kg, approximately 3.5 hr apart. Thirty minutes before administration of the second cocaine dose, yohimbine, 0.25 mg/kg, i.v. was administered. In control animals which did not receive atropine or yohimbine, there was no difference in the cardiovascular responses to the two cocaine doses administered on this schedule. Administration of cocaine alone increased mean arterial blood pressure 9.6 +/- 2.2 mm Hg and increased the rate-pressure product, an index of myocardial oxygen consumption, 12.6 +/- 4.7%. Coronary blood flow was increased 13.1 +/- 4%. Yohimbine pretreatment significantly enhanced the cardiovascular actions of cocaine and this enhancement was most pronounced in the presence of atropine. When cocaine was administered after treatment with both atropine and yohimbine, mean arterial blood pressure was increased 44.2 +/- 7.2 mm Hg, heart rate was increased 30 +/- 7.9 beats/min and the rate-pressure product was increased by 72 +/- 10.1%, whereas coronary blood flow was increased only 42.8 +/- 12%. These data suggest that presynaptic alpha adrenergic and cholinergic muscarinic blockade may significantly increase the risk of cocaine-induced cardiovascular toxicity. |
| | |
Authors:
|
R D Wilkerson |
Related Documents
:
|
6865468 - Comparison of distribution beyond coronary stenoses of blood and asanguineous cardiople... 17670358 - Intermittent pressure elevation of the coronary venous system as a method to protect is... 630688 - Coronary sinus reflux. a source of error in the measurement of thermodilution coronary ... 2528728 - Changes in nonmyocyte tissue composition associated with pressure overload of hypertrop... 12352048 - Recruitment maneuver: does it promote bacterial translocation? 6702628 - Comparative efficacy and safety of lofexidine and clonidine in mild to moderately sever... |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: The Journal of pharmacology and experimental therapeutics Volume: 248 ISSN: 0022-3565 ISO Abbreviation: J. Pharmacol. Exp. Ther. Publication Date: 1989 Jan |
Date Detail:
|
Created Date: 1989-03-03 Completed Date: 1989-03-03 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 0376362 Medline TA: J Pharmacol Exp Ther Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 57-61 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology, Medical College of Ohio, Toledo. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Atropine / pharmacology* Blood Pressure / drug effects Cardiovascular System / drug effects* Cocaine / pharmacology* Coronary Circulation / drug effects Dogs Heart Rate / drug effects Myocardial Contraction / drug effects N-Methylscopolamine Norepinephrine / metabolism Oxygen Consumption / drug effects Scopolamine Derivatives / pharmacology Yohimbine / pharmacology* |
| Grant Support | |
ID/Acronym/Agency:
|
DA 04038/DA/NIDA NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Scopolamine Derivatives; 13265-10-6/N-Methylscopolamine; 146-48-5/Yohimbine; 50-36-2/Cocaine; 51-41-2/Norepinephrine; 51-55-8/Atropine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Renal clearance of substituted hippurates in the dog. II. 4-Amino-, hydroxy- and methoxy-substituted...
Next Document: Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on lipid synthesis and lipogenic enzymes in the rat.